{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:35:01Z","timestamp":1768408501383,"version":"3.49.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41585-018-0040-y","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T09:29:26Z","timestamp":1530091766000},"page":"574-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The case for nonsurgical therapy of nonmetastatic penile cancer"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-4473","authenticated-orcid":false,"given":"Jonathan","family":"Tward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"40_CR1","first-page":"260","volume":"18","author":"H Friedenwald","year":"1917","unstructured":"Friedenwald, H. The prayer of Maimonides. Bull. Johns Hopkins Hospital 18, 260\u2013261 (1917).","journal-title":"Bull. Johns Hopkins Hospital"},{"key":"40_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.juro.2014.04.014","volume":"192","author":"JM Kieffer","year":"2014","unstructured":"Kieffer, J. M. et al. Quality of life for patients treated for penile cancer. J. Urol. 192, 1105\u20131110 (2014).","journal-title":"J. Urol."},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1464-410X.1994.tb09200.x","volume":"74","author":"S Opjordsmoen","year":"1994","unstructured":"Opjordsmoen, S. & Fossa, S. D. Quality of life in patients treated for penile cancer. A follow-up study. Br. J. Urol. 74, 652\u2013657 (1994).","journal-title":"Br. J. Urol."},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3322\/canjclin.34.2.66","volume":"34","author":"LR Schover","year":"1984","unstructured":"Schover, L. R., von Eschenbach, A. C., Smith, D. B. & Gonzalez, J. Sexual rehabilitation of urologic cancer patients: a practical approach. CA Cancer J. Clin. 34, 66\u201374 (1984).","journal-title":"CA Cancer J. Clin."},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejon.2013.06.004","volume":"17","author":"K Witty","year":"2013","unstructured":"Witty, K. et al. The impact of surgical treatment for penile cancer \u2014 patients\u2019 perspectives. Eur. J. Oncol. Nurs. 17, 661\u2013667 (2013).","journal-title":"Eur. J. Oncol. Nurs."},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archsurg.1997.01430280012001","volume":"132","author":"B Cady","year":"1997","unstructured":"Cady, B. Basic principles in surgical oncology. Arch. Surg. 132, 338\u2013346 (1997).","journal-title":"Arch. Surg."},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.08.013","volume":"88","author":"LM Burt","year":"2014","unstructured":"Burt, L. M., Shrieve, D. C. & Tward, J. D. Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 88, 94\u2013100 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000020298","volume":"38","author":"D Gotsadze","year":"2000","unstructured":"Gotsadze, D., Matveev, B., Zak, B. & Mamaladze, V. Is conservative organ-sparing treatment of penile carcinoma justified? Eur. Urol. 38, 306\u2013312 (2000).","journal-title":"Eur. Urol."},{"key":"40_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2006.03.063","volume":"176","author":"AP Lont","year":"2006","unstructured":"Lont, A. P., Gallee, M. P., Meinhardt, W., van Tinteren, H. & Horenblas, S. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J. Urol. 176, 575\u2013580; discussion 580 (2006).","journal-title":"J. Urol."},{"key":"40_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/j.1464-410X.2007.07168.x","volume":"100","author":"T Mistry","year":"2007","unstructured":"Mistry, T., Jones, R. W., Dannatt, E., Prasad, K. K. & Stockdale, A. D. A. 10-year retrospective audit of penile cancer management in the UK. BJU Int. 100, 1277\u20131281 (2007).","journal-title":"BJU Int."},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ijrobp.2006.05.053","volume":"66","author":"M Ozsahin","year":"2006","unstructured":"Ozsahin, M. et al. Treatment of penile carcinoma: to cut or not to cut? Int. J. Radiat. Oncol. Biol. Phys. 66, 674\u2013679 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","volume":"35","author":"DH Tang","year":"2017","unstructured":"Tang, D. H. et al. Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol.\u00a0Oncol. 35, 605.e17\u2013605.e23 (2017).","journal-title":"Urol. Oncol."},{"key":"40_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0959-8049(00)00368-3","volume":"37","author":"A Zouhair","year":"2001","unstructured":"Zouhair, A. et al. Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis? Eur. J. Cancer 37, 198\u2013203 (2001).","journal-title":"Eur. J. Cancer"},{"key":"40_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0676-9","volume":"11","author":"A Cordoba","year":"2016","unstructured":"Cordoba, A. et al. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients). Radiat. Oncol. 11, 96 (2016).","journal-title":"Radiat. Oncol."},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00345-008-0309-5","volume":"27","author":"J Crook","year":"2009","unstructured":"Crook, J., Ma, C. & Grimard, L. Radiation therapy in\u00a0the management of the primary penile tumor: an\u00a0update. World J. Urol. 27, 189\u2013196 (2009).","journal-title":"World J. Urol."},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ijrobp.2008.09.054","volume":"74","author":"R Crevoisier de","year":"2009","unstructured":"de Crevoisier, R. et al. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N\u2212 or NX). Int. J. Radiat. Oncol. Biol. Phys. 74, 1150\u20131156 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0360-3016(92)91062-R","volume":"24","author":"M Delannes","year":"1992","unstructured":"Delannes, M., Malavaud, B., Douchez, J., Bonnet, J. & Daly, N. J. Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 24, 479\u2013483 (1992).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","volume":"99","author":"A Escande","year":"2017","unstructured":"Escande, A. et al. Brachytherapy for conservative treatment of invasive penile carcinoma: prognostic factors and long-term analysis of outcome. Int. J. Radiat. Oncol. Biol. Phys. 99, 563\u2013570 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR19","first-page":"25","volume":"12","author":"AE Kiltie","year":"2000","unstructured":"Kiltie, A. E., Elwell, C., Close, H. J. & Ash, D. V. Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Clin.\u00a0Oncol. (R. Coll. Radiol) 12, 25\u201331 (2000).","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/0360-3016(84)90268-2","volume":"10","author":"JJ Mazeron","year":"1984","unstructured":"Mazeron, J. J. et al. Interstitial radiation therapy for\u00a0carcinoma of the penis using iridium 192 wires: the\u00a0Henri Mondor experience 1970\u20131979. Int. J.\u00a0Radiat. Oncol. Biol. Phys. 10, 1891\u20131895 (1984).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0360-3016(93)90008-J","volume":"25","author":"M McLean","year":"1993","unstructured":"McLean, M. et al. The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 25, 623\u2013628 (1993).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0167-8140(95)01574-Z","volume":"36","author":"R Rozan","year":"1995","unstructured":"Rozan, R. et al. Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother. Oncol. 36, 83\u201393 (1995).","journal-title":"Radiother. Oncol."},{"key":"40_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ijrobp.2004.10.016","volume":"62","author":"JM Crook","year":"2005","unstructured":"Crook, J. M., Jezioranski, J., Grimard, L., Esche, B. & Pond, G. Penile brachytherapy: results for 49 patients. Int. J. Radiat. Oncol. Biol. Phys. 62, 460\u2013467 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","volume":"188","author":"P Philippou","year":"2012","unstructured":"Philippou, P. et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J. Urol. 188, 803\u2013808 (2012).","journal-title":"J. Urol."},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1464-410X.2004.05153.x","volume":"94","author":"P Pietrzak","year":"2004","unstructured":"Pietrzak, P., Corbishley, C. & Watkin, N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 94, 1253\u20131257 (2004).","journal-title":"BJU Int."},{"key":"40_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0090-4295(01)01152-9","volume":"58","author":"B Ubrig","year":"2001","unstructured":"Ubrig, B., Waldner, M., Fallahi, M. & Roth, S. Preputial flap for primary closure after excision of tumors on the glans penis. Urology 58, 274\u2013276 (2001).","journal-title":"Urology"},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0022-5347(05)65650-9","volume":"166","author":"BP Bezooijen van","year":"2001","unstructured":"van Bezooijen, B. P., Horenblas, S., Meinhardt, W. & Newling, D. W. Laser therapy for carcinoma in situ of the penis. J. Urol. 166, 1670\u20131671 (2001).","journal-title":"J. Urol."},{"key":"40_CR28","unstructured":"Amin, M. B. et al. (eds) AJCC Cancer Staging Manual 8th edn (Springer, 2016)."},{"key":"40_CR29","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0022-5347(05)01003-7","volume":"175","author":"V Ficarra","year":"2006","unstructured":"Ficarra, V. et al. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J. Urol. 175, 1700\u20131705 (2006).","journal-title":"J. Urol."},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","volume":"161","author":"GP Haas","year":"1999","unstructured":"Haas, G. P. et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J. Urol. 161, 1823\u20131825 (1999).","journal-title":"J. Urol."},{"key":"40_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bju.14013","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi, A. et al. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study. BJU Int. 121, 348\u2013356 (2018).","journal-title":"BJU Int."},{"key":"40_CR32","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro, L. C. et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J. Clin. Oncol. 28, 3851\u20133857 (2010).","journal-title":"J. Clin. Oncol."},{"key":"40_CR33","doi-asserted-by":"publisher","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","volume":"33","author":"P Sharma","year":"2015","unstructured":"Sharma, P. et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol. Oncol. 33, 496.e17\u2013496.e23 (2015).","journal-title":"Urol. Oncol."},{"key":"40_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","volume":"186","author":"KN Franks","year":"2011","unstructured":"Franks, K. N. et al. Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J. Urol. 186, 524\u2013529 (2011).","journal-title":"J. Urol."},{"key":"40_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","volume":"15","author":"A Necchi","year":"2017","unstructured":"Necchi, A. et al. Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: results of a multicenter analysis. Clin. Genitourinary Cancer 15, 548\u2013555.e3 (2017).","journal-title":"Clin. Genitourinary Cancer"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/1097-0142(19850915)56:6<1257::AID-CNCR2820560606>3.0.CO;2-A","volume":"56","author":"F Edsmyr","year":"1985","unstructured":"Edsmyr, F., Andersson, L. & Esposti, P. L. Combined bleomycin and radiation therapy in carcinoma of the penis. Cancer 56, 1257\u20131263 (1985).","journal-title":"Cancer"},{"key":"40_CR37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3109\/02841868909092268","volume":"28","author":"AG Maiche","year":"1989","unstructured":"Maiche, A. G. Combined bleomycin and radiation treatment of penile carcinoma. Acta Oncol. 28, 548\u2013549 (1989).","journal-title":"Acta Oncol."},{"key":"40_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/02841869309092447","volume":"32","author":"H Modig","year":"1993","unstructured":"Modig, H., Duchek, M. & Sjodin, J. G. Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol. 32, 653\u2013655 (1993).","journal-title":"Acta Oncol."},{"key":"40_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clgc.2014.03.009","volume":"12","author":"GR Pond","year":"2014","unstructured":"Pond, G. R. et al. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clin. Genitourin Cancer 12, 440\u2013446 (2014).","journal-title":"Clin. Genitourin Cancer"},{"key":"40_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0936-6555(05)80230-4","volume":"5","author":"F Neave","year":"1993","unstructured":"Neave, F., Neal, A. J., Hoskin, P. J. & Hope-Stone, H. F. Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin. Oncol. (R. Coll. Radiol) 5, 207\u2013210 (1993).","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"40_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0360-3016(97)00068-0","volume":"38","author":"R Sarin","year":"1997","unstructured":"Sarin, R., Norman, A. R., Steel, G. G. & Horwich, A. Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. Int. J.\u00a0Radiat. Oncol. Biol. Phys. 38, 713\u2013722 (1997).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1524-4725.1987.tb02427.x","volume":"13","author":"MD Brown","year":"1987","unstructured":"Brown, M. D., Zachary, C. B., Grekin, R. C. & Swanson, N. A. Penile tumors: their management by Mohs micrographic surgery. J. Dermatol. Surg. Oncol. 13, 1163\u20131167 (1987).","journal-title":"J. Dermatol. Surg. Oncol."},{"key":"40_CR43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.juro.2007.07.039","volume":"178","author":"AW Shindel","year":"2007","unstructured":"Shindel, A. W. et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J.\u00a0Urol. 178, 1980\u20131985 (2007).","journal-title":"J. Urol."},{"key":"40_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.eururo.2008.01.019","volume":"54","author":"G Bandieramonte","year":"2008","unstructured":"Bandieramonte, G. et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur. Urol. 54, 875\u2013882 (2008).","journal-title":"Eur. Urol."},{"key":"40_CR45","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/S0022-5347(05)64158-4","volume":"168","author":"D Frimberger","year":"2002","unstructured":"Frimberger, D. et al. Penile carcinoma. Is Nd:YAG laser therapy radical enough? J. Urol. 168, 2418\u20132421; discussion 2421 (2002).","journal-title":"J. Urol."},{"key":"40_CR46","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.urology.2007.01.023","volume":"69","author":"RP Meijer","year":"2007","unstructured":"Meijer, R. P., Boon, T. A., van Venrooij, G. E. & Wijburg, C. J. Long-term follow-up after laser therapy for penile carcinoma. Urology 69, 759\u2013762 (2007).","journal-title":"Urology"},{"key":"40_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1464-410X.2009.09188.x","volume":"106","author":"B Schlenker","year":"2010","unstructured":"Schlenker, B. et al. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 106, 786\u2013790 (2010).","journal-title":"BJU Int."},{"key":"40_CR48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0090-4295(98)00308-2","volume":"52","author":"DN Tietjen","year":"1998","unstructured":"Tietjen, D. N. & Malek, R. S. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 52, 559\u2013565 (1998).","journal-title":"Urology"},{"key":"40_CR49","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1097\/01.ju.0000067361.81295.a2","volume":"169","author":"T Windahl","year":"2003","unstructured":"Windahl, T. & Andersson, S. O. Combined laser treatment for penile carcinoma: results after long-term followup. J. Urol. 169, 2118\u20132121 (2003).","journal-title":"J. Urol."},{"key":"40_CR50","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0022-5347(05)63942-0","volume":"169","author":"NK Bissada","year":"2003","unstructured":"Bissada, N. K. et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J. Urol. 169, 500\u2013502 (2003).","journal-title":"J. Urol."},{"key":"40_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","volume":"54","author":"JA Leijte","year":"2008","unstructured":"Leijte, J. A., Kirrander, P., Antonini, N., Windahl, T. & Horenblas, S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur. Urol. 54, 161\u2013168 (2008).","journal-title":"Eur. Urol."},{"key":"40_CR52","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Genomic profiling of penile squamous cell carcinoma reveals new opportunities for\u00a0targeted therapy. Cancer Res. 75, 5219\u20135227 (2015).","journal-title":"Cancer Res."},{"key":"40_CR53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"LA Cubilla.","year":"2018","unstructured":"Cubilla., L. A. et al. The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72, 893\u2013904 (2018).","journal-title":"Histopathology"},{"key":"40_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","volume":"21","author":"SM Ali","year":"2016","unstructured":"Ali, S. M. et al. Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations. Oncologist 21, 33\u201339 (2016).","journal-title":"Oncologist"},{"key":"40_CR55","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/annonc\/mdw152","volume":"27","author":"JH Chung","year":"2016","unstructured":"Chung, J. H. et al. Comprehensive genomic profiling of\u00a0anal squamous cell carcinoma reveals distinct genomically defined classes. Ann. Oncol. 27, 1336\u20131341 (2016).","journal-title":"Ann. Oncol."},{"key":"40_CR56","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1200\/jco.2015.33.15_suppl.5602","volume":"33","author":"JA Elvin","year":"2015","unstructured":"Elvin, J. A. et al. Comprehensive genomic profiling (CGP) of cervical squamous cell carcinoma (cSCC) to identifiy targeted therapy options. J. Clin. Oncol. 33, 5602\u20135602 (2015).","journal-title":"J. Clin. Oncol."},{"key":"40_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2013","unstructured":"Ojesina, A. I. et al. Landscape of genomic alterations in cervical carcinomas. Nature 506, 371\u2013375 (2013).","journal-title":"Nature"},{"key":"40_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.semdp.2011.06.001","volume":"29","author":"A Chaux","year":"2012","unstructured":"Chaux, A., Velazquez, E. F., Barreto, J. E., Ayala, E. & Cubilla, A. L. New pathologic entities in penile carcinomas: an update of the 2004 World Health Organization Classification. Semin. Diagn. Pathol. 29, 59\u201366 (2012).","journal-title":"Semin. Diagn. Pathol."},{"key":"40_CR59","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"GT Wolf","year":"1991","unstructured":"Wolf, G. T. et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J.\u00a0Med. 324, 1685\u20131690 (1991).","journal-title":"N. Engl. J. Med."},{"key":"40_CR60","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","volume":"17","author":"CW Whitney","year":"1999","unstructured":"Whitney, C. W. et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17, 1339\u20131348 (1999).","journal-title":"J. Clin. Oncol."},{"key":"40_CR61","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","volume":"22","author":"PJ Eifel","year":"2004","unstructured":"Eifel, P. J. et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u201301. J. Clin. Oncol. 22, 872\u2013880 (2004).","journal-title":"J. Clin. Oncol."},{"key":"40_CR62","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose, P. G. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340, 1144\u20131153 (1999).","journal-title":"N. Engl. J. Med."},{"key":"40_CR63","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters 3rd","year":"2000","unstructured":"Peters, W. A. 3rd et al. Concurrent chemotherapy and\u00a0pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18, 1606\u20131613 (2000).","journal-title":"J. Clin. Oncol."},{"key":"40_CR64","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys, H. M. et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N.\u00a0Engl. J. Med. 340, 1154\u20131161 (1999).","journal-title":"N. Engl. J. Med."},{"key":"40_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/bmj.318.7184.623","volume":"318","author":"D Josefson","year":"1999","unstructured":"Josefson, D. Adding chemotherapy improves survival in cervical cancer. BMJ 318, 623\u2013623 (1999).","journal-title":"BMJ"},{"key":"40_CR66","first-page":"CD008285","volume":"1","author":"Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration","year":"2010","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst. Rev. 1, CD008285 (2010).","journal-title":"Cochrane Database Syst. Rev."},{"key":"40_CR67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein, D. J. et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 21, 92\u201398 (2003).","journal-title":"J. Clin. Oncol."},{"key":"40_CR68","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","volume":"91","author":"G Calais","year":"1999","unstructured":"Calais, G. et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J.\u00a0Natl Cancer Inst. 91, 2081\u20132086 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"40_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1470-2045(09)70306-7","volume":"11","author":"JS Tobias","year":"2010","unstructured":"Tobias, J. S. et al. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet. Oncol. 11, 66\u201374 (2010).","journal-title":"Lancet. Oncol."},{"key":"40_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2006.09.018","volume":"67","author":"B Zakotnik","year":"2007","unstructured":"Zakotnik, B. et al. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with mitomycin C and bleomycin. Int. J.\u00a0Radiat. Oncol. Biol. Phys. 67, 685\u2013690 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"40_CR71","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","volume":"114","author":"C Kunos","year":"2009","unstructured":"Kunos, C., Simpkins, F., Gibbons, H., Tian, C. & Homesley, H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstetr. Gynecol. 114, 537\u2013546 (2009).","journal-title":"Obstetr. Gynecol."},{"key":"40_CR72","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro, N. D., Vaitkevicius, V. K. & Considine, B. Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis. Colon Rectum 17, 354\u2013356 (1974).","journal-title":"Dis. Colon Rectum"},{"key":"40_CR73","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/BF02553933","volume":"27","author":"ND Nigro","year":"1984","unstructured":"Nigro, N. D. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis. Colon Rectum 27, 763\u2013766 (1984).","journal-title":"Dis. Colon Rectum"},{"key":"40_CR74","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink, H. et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J. Clin. Oncol. 15, 2040\u20132049 (1997).","journal-title":"J. Clin. Oncol."},{"key":"40_CR75","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover, J. et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br.\u00a0J. Cancer 102, 1123\u20131128 (2010).","journal-title":"Br. J. Cancer"},{"key":"40_CR76","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani, J. A. et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299, 1914\u20131921 (2008).","journal-title":"JAMA"},{"key":"40_CR77","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James, R. D. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial. Lancet. Oncol. 14, 516\u2013524 (2013).","journal-title":"Lancet. Oncol."},{"key":"40_CR78","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Anal Carcinoma. NCCN \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/colorectal\/english\/anal.pdf\n                    \n                   (2017)."},{"key":"40_CR79","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","volume":"16","author":"MA Henderson","year":"2015","unstructured":"Henderson, M. A. et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol. 16, 1049\u20131060 (2015).","journal-title":"Lancet Oncol."},{"key":"40_CR80","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0022-5347(01)65471-5","volume":"156","author":"A Lopes","year":"1996","unstructured":"Lopes, A. et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J. Urol. 156, 1637\u20131642 (1996).","journal-title":"J. Urol."},{"key":"40_CR81","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Penile Cancer. NCCN \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/urological\/english\/penile.pdf\n                    \n                   (2016)."},{"key":"40_CR82","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Vulvar Cancer. NCCN \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/vulvar.pdf\n                    \n                   (2016)."},{"key":"40_CR83","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers. NCCN \n                    https:\/\/oralcancerfoundation.org\/wp-content\/uploads\/2016\/09\/head-and-neck.pdf\n                    \n                   (2016)."},{"key":"40_CR84","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Cancer. NCCN \n                    http:\/\/tsqb.hnszlyy.com\/ueditor\/upload\/NCCN%20Guidelines%20esophageal%20cancer%20(2017%20V1)_2017112723507.pdf\n                    \n                   (2017)."},{"key":"40_CR85","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. NCCN \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/lung\/english\/non_small.pdf\n                    \n                   (2015)."},{"key":"40_CR86","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical cancer. NCCN \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/cervical.pdf\n                    \n                   (2016)."},{"key":"40_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg, O. W. et al. EAU guidelines on penile cancer: 2014 update. Eur. Urol. 67, 142\u2013150 (2015).","journal-title":"Eur. Urol."},{"key":"40_CR88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000327453","volume":"5","author":"B O\u2019Neil","year":"2011","unstructured":"O\u2019Neil, B., Brant, W. O., Slack, S. D., Tward, J. D. & Myers, J. B. Penile cancer: contemporary considerations in management of local disease. Curr.\u00a0Urol. 5, 62\u201371 (2011).","journal-title":"Curr. Urol."},{"key":"40_CR89","first-page":"4","volume":"2014","author":"A Chhabra","year":"2014","unstructured":"Chhabra, A. et al. Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma. Case Rep. Oncol. Med. 2014, 4 (2014).","journal-title":"Case Rep. Oncol. Med."},{"key":"40_CR90","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canrad.2016.10.003","volume":"21","author":"A Lapierre","year":"2017","unstructured":"Lapierre, A., Riou, O., Flechon, A., Mottet, N. & Azria, D. Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine. Cancer Radiother. 21, 134\u2013137 (2017).","journal-title":"Cancer Radiother."},{"key":"40_CR91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MOU.0000000000000346","volume":"27","author":"J Crook","year":"2017","unstructured":"Crook, J. Radiotherapy approaches for locally advanced penile cancer: neoadjuvant and adjuvant. Curr. Opin. Urol. 27, 62\u201367 (2017).","journal-title":"Curr. Opin. Urol."},{"key":"40_CR92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3322\/CA.2008.0006","volume":"58","author":"D Stacey","year":"2008","unstructured":"Stacey, D., Samant, R. & Bennett, C. Decision making in oncology: a review of patient decision aids to support patient participation. CA Cancer J. Clin. 58, 293\u2013304 (2008).","journal-title":"CA Cancer J. Clin."},{"key":"40_CR93","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/erp.12.3","volume":"12","author":"RL Street","year":"2012","unstructured":"Street, R. L., Elwyn, G. & Epstein, R. M. Patient preferences and healthcare outcomes: an ecological perspective. Expert Rev. Pharmacoeconom. Outcomes Res. 12, 167\u2013180 (2012).","journal-title":"Expert Rev. Pharmacoeconom. Outcomes Res."},{"key":"40_CR94","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00520-014-2221-4","volume":"22","author":"A Zucca","year":"2014","unstructured":"Zucca, A., Sanson-Fisher, R., Waller, A. & Carey, M. Patient-centred care: making cancer treatment centres accountable. Supportive Care Cancer 22, 1989\u20131997 (2014).","journal-title":"Supportive Care Cancer"},{"key":"40_CR95","volume-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine (US) Committee on Quality of Health care in America","year":"2001","unstructured":"Institute of Medicine (US) Committee on Quality of Health care in America. Crossing the Quality Chasm: A\u00a0New Health System for the 21st Century (National Academies Press, Washington, 2001)."},{"key":"40_CR96","volume-title":"Through the Patient\u2019s Eyes: Understanding and Promoting Patient-Centered Care","year":"1993","unstructured":"Gerteis, M., Edgman-Levitan, S., Daley, J. & Delbanco, T. L. (eds). Through the Patient\u2019s Eyes: Understanding and Promoting Patient-Centered Care. (Jossey-Bass, San Francisco, 1993)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0040-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-018-0040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:24:01Z","timestamp":1684621441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-018-0040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1038\/s41585-018-0040-y","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"27 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}